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Abstract
Non-invasive brain stimulation (NIBS) is increasingly proposed as a therapeutic interven-
tion for many neurological and psychiatric disorders, including pain, depression, obsessive 
compulsive disorder, and anxiety. While neuromodulation as an intervention for pain relief 
has a well-established scientific basis, evidence is largely restricted to invasive stimulation 
that targets the spinal cord. Novel non-invasive methodologies instead predominately 
target cortical processing of pain and thus raise interesting questions about how the most 
effective pain relief can be achieved. Functional magnetic resonance imaging (fMRI) stud-
ies show a widespread and distributed activation of brain areas during pain. This diverse 
activity is often referred to as the “pain neuromatrix” and can lead to the proposal for 
different possible target areas for pain relief. Neuromodulation could target brain regions 
of pain processing areas responsible for sensorimotor processing or alternatively regions 
responsible for the affective and evaluative aspects of the subjective pain experience. The 
chapter addresses the different approaches currently taken in the use of non-invasive neu-
romodulation for altering pain both in an experimental setting and the challenges involved 
in the translation of these techniques to a diverse range of chronic pain conditions.
Keywords: pain, neurostimulation, transcranial magnetic stimulation, transcranial 
direct current stimulation, quantitative sensory testing
1. Introduction
The International Association for the Study of Pain (IASP) defines pain as “an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage or 
described in terms of such damage” [1]. Nociception is an indispensable survival mechanism 
designed to minimize tissue injury, observed across species from the simplest invertebrate 
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model systems. Its critical function as a sense for survival is reflected by its emergence early 
developmentally. In all animals, the characteristic perception of nociceptive stimuli is rapid 
reflexive movement away from the source of the noxious stimulus (nocifensive behavior) and 
autonomic responses that optimize the ability to escape from threats [2]. In humans, pain 
encompasses not only these sensorimotor responses but critically also the cognitive evaluative 
component, and the IASP definition encompasses the subjectivity of the pain phenomenon.
Chronic pain represents a significant health burden worldwide with over 1.5 million people 
suffering from chronic pain globally [3]. Nearly 20% of those in Europe are believed to be in 
chronic pain, and lifetime prevalence of chronic pain worldwide has been put as high as 55.2% 
of the population [4, 5]. The experience of pain is known to have a substantial detrimental 
impact on an individual’s quality of life and mental health status. Extensive research has docu-
mented the high correlation between pain and mental health difficulties, not just within clinical 
cohorts but also in community-based studies [6]. Pain can therefore be seen as an important risk 
factor for the development of psychiatric conditions, for instance, depression. Furthermore, 
there is a reciprocal nature to the interaction, with depression likely to exacerbate the indi-
vidual’s experience of pain [7]. Overall, the consequence is not just on the individual but also 
the societal economic burden of pain will be further compounded by the economic burden of 
the concomitant mental health difficulties of those experiencing it chronically.
2. Pain and pain processing
Noxious stimuli are detected by the free endings of pseudounipolar neurons (Aδ or C fibers) 
which project to the dorsal horn of the spinal cord to synapse with second-order neurons in 
laminae I–II and V–VII [2]. Type I small-diameter thinly myelinated Aδ fibers respond to strong 
mechanical stimuli; type II Aδ nociceptors respond to noxious thermal stimuli; unmyelinated 
C-fiber nociceptors respond to thermal, mechanical, and chemical stimuli [2]. Neurons of lami-
nae I and V relay signals along the spinothalamic and spinoreticulothalamic tracts to supra-
spinal sites including the thalamus, parabrachial nucleus, and amygdala and to higher cortical 
centers such as the primary somatosensory cortex (S1), secondary somatosensory cortex (S2), 
dorsolateral prefrontal cortex (DLPFC), and primary motor cortex (M1). Taken together, the 
combined activity of both cortical and subcortical regions that form a distributed brain network 
associated with pain processing is referred to as the pain “neuromatrix” [8]. The ventropos-
terior lateral and medial nuclei of the thalamus, S1 and S2 are concerned with the sensory-
discriminative component of pain, encoding location, and duration of pain, whereas the medial 
nuclei of the thalamus and anterior cingulate cortex (ACC) are regions suggested to underlie 
the cognitive-evaluative aspect of pain, including pain-related learning [2]. Descending path-
ways pass through the periaqueductal gray matter (PAG), which has been long established as 
important in the endogenous modulation of pain via early electrical stimulation studies [9]. 
The PAG is part of a central circuit that controls nociceptive transmission at the level of the 
spinal cord dorsal horn via a relay in the rostral ventromedial medulla (RVM) [10]. The PAG 
receives direct projections from a number of medial prefrontal cortical areas, including the 
ACC, the amygdala, and the hypothalamus [11–14], with a primary output to the RVM critical 
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to descending pain modulation. The PAG-RVM system’s critical role in the central control of 
nociception has been demonstrated by lesion studies [15]. Taken together, these studies indicate 
that the intensity of pain will be the consequence and composite of interactions between ascend-
ing nociceptive inputs and descending antinociceptive controls. Dysregulations in any aspect 
of these networks may underlie vulnerability factors for the development of chronic pain [16].
2.1. Pain and the chronification of pain
While acute pain is highly functional to survival and an adaptive sense that is protective against 
tissue damage, the mechanisms behind the development from this protective function to the 
maladaptive disease of chronic pain in a proportion of individuals remain elusive. Chronic 
pain is defined as pain that persists for 3–6 months after the initial nociceptive stimuli [17]. 
Methodologies that have potential to predict individual patients with pain who are at risk of 
developing chronic pain would be particularly valuable at helping to understand the physi-
ological mechanisms behind this very detrimental disease process. Recent research suggests that 
the use of computational machine learning methods to analyze large data sets of medical and 
demographic characteristics collected from patients who develop chronic pain patients may aid 
understanding of the risk factors underlying chronification and a possible chronic pain pheno-
type [18]. This is an interesting concept, though ultimately dependent on the relevant predictors 
of pain chronification being in the analyzed data set. For instance, while there has been recent 
interest in the use of quantitative sensory testing to characterize individual differences in pain 
sensitivity, thorough assessment of pain thresholds across a variety of modalities, this is by no 
means standard. That limitation aside, greater understanding of pain chronification is essential 
for the development of interventions for chronic pain and increased understanding of how to 
effectively disrupt the transition into a disease state. In the future, the inclusion of larger data sets 
will inevitably increase the predictive value of this emerging technique.
Chronic pain is characterized by increases in neuronal excitability leading to increased pain 
perception. These increases in excitability are believed to occur both peripherally and cen-
trally, factoring into the overall elevated perceived pain. To date, research has predominately 
focused on spinal cord mechanisms. This perhaps is somewhat related to availability of 
appropriate animal models and the existing strong scientific basis. However, it is well estab-
lished that spinal cord excitability can be modulated by descending pathways. Given the role 
of descending pathways in modulating excitability in the spinal cord, the input and impact 
of a wide range of cortical areas in perceived pain should be systematically considered and 
characterized. These cortical areas will not just include those directly related to sensorimotor 
processing but also encompass those areas important for the cognitive evaluative and emo-
tional response to pain. NIBS techniques may provide a tool that can enable further insight 
into the mechanisms of pain processing from periphery through to cortex that may in turn 
reveal potential therapeutics for the treatment of chronic pain conditions.
Further, pain is categorized by the IASP as either neuropathic or nociceptive [19]. Neuropathic 
pain is a pain that is caused by a disorder of the somatosensory system and typically leads 
to symptoms that include hyperalgesia, allodynia, and pain in the absence of stimulation. 
Nociceptive pain is a pain that arises from damage to non neural tissue via the activation of 
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nociceptors. Another consideration is that although there is a broad distinction into neuro-
pathic and nociceptive pain, there can be overlap in the two forms of pain, as well as the fact 
that pain can arise from a vast range of different underlying pathologies.
3. Neurostimulation for pain modulation
The use of electricity to alleviate pain has a long history, with the reported use of the electric 
emissions from the Nile catfish for pain relief in 3100 BC. Although there has been use of elec-
trical stimulation continually, the groundbreaking gate control theory of Melzack and Wall 
published in 1965 changed the field and provided a strong basis for the design of appropriate 
interventions [20]. The theory proposes that the balance of activation between small- and 
larger diameter fibers determines the level of pain signaled. Small-diameter C fibers will open 
the “gate,” and Aβ fibers (that signal innocuous touch), having a larger diameter, will close 
the “gate.” Due to differences in the threshold of activation of these fibers in response to 
imposed electrical stimulation on a mixed nerve, a simple intervention to shift the balance of 
activation is possible. Neuromodulation of pain through electrical stimulation of implanted 
electrodes has substantial supportive evidence since its initial introduction in spinal cord 
stimulation (SCS) in 1967 [21] and is accepted as a standard form of treatment for intractable 
chronic neuropathic pain. Many of these implantable neurostimulation devices were adapted 
from the design of cardiac pacemakers, and their design and stimulation parameters have not 
changed substantially since their initial introduction. However, differences do exist among 
SCSs; for instance, some are based on tonic stimulation, whereas others on burst stimulation, 
and the stimulation frequency can be varied.
Other invasive stimulators have targeted pain pathways in the brain to alleviate pain, often 
utilizing the knowledge of role of the thalamus as having a critical role in sensory process-
ing. Deep brain stimulation (DBS) has been applied to different thalamic nuclei, including 
the ventral posteromedial sensory nuclei and ventral posterolateral sensory nuclei and the 
centromedian-parafascicular intralaminar region. There is widely varying reports of the effec-
tiveness of DBS of the thalamus but with the strongest response believed to be in patients 
with neuropathic pain [22]. DBS has also included stimulation of the ACC, with the aim of 
reducing the affective component of chronic pain, and this has been shown to be effective 
within small studies [23].
The primary motor cortex (M1) was the first cortical target that was proven to be efficacious in 
chronic pain treatment [24]. Motor Cortex Stimulation (MCS), where epidural electrodes are 
implanted has been shown to be a particularly useful intervention for neuropathic pain that 
is not responsive to pharmacological interventions [25, 26]. The primary motor cortex (M1) 
is somatotopically arranged and receives inputs from three main sources. These are [1] the 
peripheral body via the thalamic relay nuclei-somatosensory cortex system, from the premo-
tor cortex and from the sensory association areas of the cortex; [2] the basal ganglia; and [3] 
from the cerebellum. Therefore, there is considerably overlap with motor processing areas 
and those associated with the pain neuromatrix. It is believed that cathodal MCS is associated 
with an indirect stimulation of pyramidal neurons via interneurons, whereas anodal MCS is 
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associated with a direct stimulation of pyramidal neurons. The indirect activation is believed 
to be optimal for MCS analgesia.
Invasive neuromodulatory devices have been the subject of research for much longer non-
invasive  neuromodulatory techniques, including randomized controlled trials. By reason of 
their very invasive nature, and obvious ethical constraints, the effectiveness and consequences 
of SCS, MCS, and DBS have only be assessed in patients and not experimentally investigated 
in healthy volunteers, which may have limited the development of different stimulation proto-
cols. Therefore, unlike these invasive stimulators, NIBS techniques potentially enable another 
important distinction to be considered, the difference in response to neuromodulation in 
chronic pain patient groups compared with healthy individuals exposed to experimental pain 
or experiencing acute pain.
4. Functional magnetic resonance imaging (fMRI) and chronic pain
Functional magnetic resonance imaging (fMRI) was first used in the area of pain in order to 
demonstrate the brain areas responsible for pain perception and part of the pain “neuroma-
trix” [28]. Subsequently, differences in the structure and function of pain patients compared 
with healthy controls have been observed through fMRI of experimental pain in both groups 
[29]. Chronic pain patients show similar activation but with a decrease in thalamic and ACC 
activation. Activity in the prefrontal cortex (PFC) typically shows an increase in clinical pain 
conditions. This preferential activation of PFC in chronic pain conditions advocates that 
chronic pain states have stronger cognitive-evaluative aspect of pain [16].
As well as functional changes, structural changes have been observed through MRI in 
patients experiencing long-term pain. Chronic pain patients are found to show neuronal loss 
in significant pain pathways including the thalamus and the lateral prefrontal cortex [30]. 
Fibromyalgia, a patient group with a particularly complex range of sensorimotor symptoms, 
shows gray matter loss in the DLPFC [31], and this is believed to be consistent across dif-
ferent chronic pain patient groups. For instance, patients with chronic lower back pain also 
show reductions in gray matter in distributed regions of the pain “neuromatrix,” including 
DLPFC. This decrease in gray matter also occurs in prolonged pain states in the general popu-
lation as well as clinical groups [32], and on resolution of persistent pain, for instance when a 
patient with knee osteoarthritis (OA) undergoes knee arthroplasty, gray matter levels increase 
in parallel.
fMRI has also been used to demonstrate the effectiveness of neuromodulatory interventions, 
as well as the scope of the effect of stimulation. For instance, functional connectivity changes 
were observed in a group of neuropathic pain patients who had undergone SCS. After 
implantation, decreased connectivity was found between somatosensory and limbic areas of 
the brain, showing how central changes can be mediated by SCS [28]. Studies using combined 
NIBS/fMRI may provide interesting insights on the effect of neuromodulation protocols on 
changes in functional connectivity of the pain neuromatrix as has been done in other treat-
ment interventions [33].
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5. Noninvasive brain stimulation: Investigative and therapeutic uses
NIBS is well established as a tool to study the physiology of the CNS, elucidate functional anatomy 
of specific brain regions and explore brain network organization and plasticity [34]. However, 
currently the application of NIBS to pain research is much more recent, although this is a rapidly 
expanding field [35]. The most commonly used forms of NIBS that aim to modulate neuronal 
plasticity are repetitive transcranial magnetic stimulation (rTMS) and transcranial direct cur-
rent stimulation (tDCS), with the techniques rapidly expanding to variations on these methods. 
Transcranial alternating current stimulation (tACS) is a particularly exciting new method where 
an alternating current is applied with the aim of enhancing network oscillations at frequencies 
close to the stimulation frequency [36]. Therefore, the rationale behind the tACS technique is that 
it may lead to pain modulation via the alteration of specific rhythmic activity known to be associ-
ated with pain processing [37], but currently, there are only a few experimental studies applying 
this technique to experimental or clinical pain. For all of these methodologies, the noninvasive 
nature, relatively low cost, and well-established safety and tolerability make these neuromodula-
tory techniques potentially important tools both for neurophysiological studies and to aid the 
development of long-term therapeutic interventions [38].
5.1. Transcranial magnetic stimulation
Transcranial magnetic stimulation (TMS) has both neuromodulatory and neurostimulatory 
properties. The technique, first introduced in 1985, has subsequently been widely used as a tool 
to study cortical brain areas, particularly motor cortex. The technique involves a stimulating coil 
of wire positioned over the desired brain target area, with a brief pulse of current passed through 
the coil, so generating a magnetic field which penetrates through the skull with negligible attenu-
ation. The rapidly changing magnetic field induces a secondary current in the subject’s brain, thus 
stimulating neural tissue via the depolarization of neurons [34]. Thus the technique overcame 
many of the problems associated with electrical stimulation, where the skull provides a barrier. 
With an appropriate figure of eight coil [39], TMS can be used to stimulate precise regions, such 
as the hand area of the motor cortex (C3). The motor cortex is a particularly good target for TMS 
usage in the absence of neuronavigation software packages that guide coil positioning over the 
appropriate brain target area as single-pulse TMS eliciting motor evoked potentials (MEPs) that 
can be recorded using electromyography (EMG), which enable the determination that the correct 
cortical area has been stimulated. MEPs are further used to determine the stimulation intensity 
required in an experimental protocol via the measurement of motor threshold and the quantifica-
tion of changes in corticospinal excitability [34, 40, 41].
Repetitive transcranial magnetic stimulation (rTMS) refers to the application of a train 
of pulses and dependent on the frequency acts to suppress or facilitate the activity in an 
underlying brain area. The stimulation of the motor cortex with low frequencies (1 Hz or 
less) is associated with a decrease in corticospinal excitability, whereas higher frequencies 
(20–50 Hz) have been associated with an increase in excitability [42]. It has been noted that 
these effects are somewhat inconsistent, thereby limiting its therapeutic applications [43]. A 
possible reason behind this is that rTMS is dependent on stimulation parameters other than 
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frequency, and baseline corticospinal excitability of the targeted brain area is a critical param-
eter in determining the consequence of rTMS [44].
5.2. Pain modulation through repetitive transcranial magnetic stimulation of  
motor cortex
Given the known efficacy of MCS for pain relief, the primary motor cortex was an obvious 
initial choice of target for NIBS interventions. Further given the corticospinal tract is known 
to have non-motor functions, that include a role in nociception, the stimulation could have an 
effect on this pathway [45].
High-frequency rTMS of the motor cortex has been shown to be efficacious in the treatment of 
pain [35, 43, 46, 47]. Significant reductions in pain ratings occur following high-frequency stimu-
lation and these stimulation effects lasting from several minutes up to 8 days and even longer 
after multiple rTMS sessions. Stimulation of the motor cortex with high-frequency rTMS showed 
significantly increased pain thresholds with regard to cold thermal stimuli, meaning rTMS 
reduced the temperature at which the cold sensation became painful [40]. This demonstrates that 
rTMS not only can modulate chronic pain, but also experimentally induced acute pain.
Evidence for M1 rTMS for pain relief is mounting, but there is still a shortage of large studies, 
and the duration of the neuromodulatory effect is not well established. Technical consider-
ations with coil positioning may alter the effectiveness of rTMS as an intervention for pain 
relief which may not be completely controlled for in different studies. In rTMS, the coil is typi-
cally placed over M1 in an anteroposterior orientation which is associated with transsynaptic 
activation of pyramidal neurons, and this placement is believed to be optimal for analgesic 
effects compared with the placement of the coil in a lateromedial orientation, similar to find-
ings with MCS [27]. Further, there is evidence that when the electrodes are placed over the 
somatotopic M1 region of the painful area, that optimal analgesic effect can be obtained [27].
The mechanisms behind M1 rTMS-facilitated analgesia are still not established. Previous 
research on implanted MCS has suggested that the modulation of pain is related to the inhibi-
tion of thalamic activity. M1 rTMS could modulate the pathways from the insula and orbi-
tofrontal cortex to the posterior thalamus in order to upregulate these pain thresholds [48]. 
The modulation of pathways from the insula could be particularly significant, given recent 
research suggesting that the insula act as the cortical generator of pain perception, integrating 
sensory and affective components of pain [2].
The neurochemical mediation of the neuromodulation is still uncertain. There is evidence that the 
endogenous opioid system may be responsible. Additionally, the activation of GABA (gamma-
Aminobutyric acid)-ergic and glutamatergic pathways may be critical. For instance, high-fre-
quency rTMS is believed to restore defective intracortical inhibition, a measure associated with 
impairments in GABAergic neurotransmission in patients with chronic pain [47]. Glutamate 
N-methyl-D-aspartate (NMDA)-receptors are also thought to be involved in rTMS neuromodu-
latory effects, in that there was observed a decrease in analgesic effects after the administration 
of the NMDA antagonist, ketamine [49]. This supports the ability of rTMS to induce synaptic 
plasticity via long-term potentiation (LTP) and long-term depression (LTD) like mechanisms.
Neurostimulation Techniques for the Modulation of Pain
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5.3. The dorsolateral prefrontal cortex
A second cortical target that has been investigated by NIBS is the DLPFC [50] The DLPFC is 
connected to the orbitofrontal cortex and to other areas of the pain “neuromatrix,” in particu-
lar the thalamus and dorsal caudate nucleus. Evidence from multimodal studies, including 
neuroimaging, TMS, and tDCS, suggests that DLPFC is important in the affective modula-
tion of pain [51–55]. The DLPFC has shared connectivity with regions associated with senso-
rimotor processing and monitoring of motor performance. This connectivity highlights the 
potential importance of the DLPFC as a target for neurostimulation for the modulation of 
pain [56]. Further, in addition to its possible ability to modulate the sensory-discriminative 
aspects of pain perception and experience, DLPFC has reciprocal networks within the ven-
tromedial prefrontal cortex supporting the integration of memory and stimulus characteris-
tics. Additionally, it has been found that increased activity in the DLPFC is associated with 
decreased pain intensity and unpleasantness.
High-frequency rTMS of the DLPFC has been shown to alleviate neuropathic pain in patient 
groups [57]. Experimentally, the effects of low-frequency rTMS on both left and right DLPFC 
have also been reported where it was found that stimulation inhibited placebo analgesia, and 
so increased heat pain ratings [51]. This finding related to placebo analgesia highlights some 
of the difficulties involved in assessing the efficacy of NIBS interventions.
Differing mechanisms have been proposed for the alleviation of pain through increased activ-
ity in the DLPFC, one is that it is able to activate descending modulatory pathways through 
the periacqueductal gray, whereas an alternative mechanism was via modulation of thalamic 
activity as has been proposed by fMRI studies [58]. There is also a proposed role for the DLPFC 
in terms of the anticipation of pain, which could provide some explanation for placebo-related 
alternations in pain thresholds. One of the difficulties that arises in the comparison of active 
treatments to placebo is the possibility of an analgesic response to the placebo itself, which 
may be mediated by endogenous opioids [59, 60]. With this in mind, the ability of NIBS to 
modulate the placebo effect is in itself interesting.
5.4. Neurophysiology of tDCS
tDCS is a non-invasive technique, where weak direct current (<2 mA) is applied on the scalp for 
10–20 mins using large saline-soaked sponge electrodes. In contrast to TMS, tDCS is neuromod-
ulatory rather than neurostimulatory and as such influences spontaneous neuronal activity by 
modulating resting membrane potentials [61]. Animal studies have demonstrated that anodal 
tDCS depolarizes membrane potentials and increases neuronal firing rates and excitability, 
whereas cathodal stimulation hyperpolarizes membrane potentials, leading to decreased excit-
ability [62]. Modeling techniques suggest that these short-term effects may be mediated by glia, 
with tDCS modulating glial transmembrane potential that may in turn alter glial regulation of 
potassium or glutamate homeostasis [63]. Due to technical difficulties, experimental evidence 
to examine the precise effect on glia is limited. Both anodal and cathodal long-term effects have 
been attributed to N-methyl-D-aspartate (NMDA)-receptor activation; the NMDA-receptor 
antagonist dextromethorphan has been reported to suppress the aftereffects of anodal and 
cathodal tDCS [64, 65]. Further, studies using magnetic resonance spectroscopy have reported 
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that anodal stimulation inhibits neurotransmission by the inhibitory neurotransmitter GABA 
[66], whereas cathodal stimulation inhibits neurotransmission by the excitatory neurotransmit-
ter glutamate [67, 68]. While the precise mechanisms remain elusive, recent research in animal 
models suggest that weak electrical stimulation acts as a modulator, rather than an inducer of 
synaptic plasticity with its effects highly dependent on endogenous synaptic activity [69].
5.5. High-definition transcranial direct current stimulation
High-definition transcranial direct current stimulation (HD-tDCS) is a technique used to 
increase the spatial focality of tDCS by using <12 mm diameter ring electrodes [70]. As an 
investigative tool, HD-tDCS holds several advantages over conventional tDCS. Neuroimaging 
and modeling studies have demonstrated that conventional parameters induced neuromodu-
lation extends outside the area covered by the target electrode [2, 71]. In addition, the larg-
est current densities for conventional tDCS may not be produced directly under the target 
electrodes [70]. In comparison to the diffuse effects of conventional tDCS, HD-tDCS enables a 
more targeted approach to neurostimulation, potentially avoiding modulation of confound-
ing brain regions and permitting isolation of certain pain processing pathways [72].
The predominant montage for HD-tDCS is a 4x1 array configuration consisting of five ring 
electrodes: 1 “active electrode” placed over the target area surrounded by a ring of 4 “return” 
electrodes placed equidistant from the central electrode [71]. This 4x1 montage increases 
intensity and focality of the stimulation, with peak stimulation situated under the central 
electrode. Further, the montage also allows for depth, focality, and intensity of stimulation to 
be titrated depending on the ring diameter [73]. In addition to improved focality, HD-tDCS 
has lower observed adverse effects, including less itching and scalp discomfort and with the 
further advantage of a longer duration of neuromodulatory effects [3]. Recent multidimen-
sional electrode arrays are now available but, thus far, very little research has been conducted.
5.6. Pain modulation using transcranial direct current stimulation
Multiple types of experimental pain have been used to study the effects of NIBS on nociceptive 
signaling in healthy human subjects [74]. tDCS of M1 produces sustained analgesia in chronic 
migraine, fibromyalgia, and orofacial pain [38]. Currently, the level of evidence for the use of 
tDCS in neuropathic pain is currently lower than that for rTMS [17, 75]. Similar to the effect of 
rTMS on DLPFC, there is also evidence that tDCS of the DLPFC modulates pain. For instance, 
anodal tDCS of the left DLPFC has been shown to increase electrical pain thresholds [76]. There 
are currently fewer studies targeting DLPFC, but future work on this area is of clear interest.
The mechanisms by which tDCS modulates pain processing have not yet been fully elucidated 
and likely differs between target brain regions. Anodal M1 tDCS increases cortical excitability 
[62] that may result in disinhibition of glutamatergic M1 neurons that activate sensory gating 
mechanisms in the thalamus via corticothalamic projections, reducing incoming nociceptive 
information to somatosensory cortex [77]. Alternatively, stimulation of M1 may stimulate 
GABAergic neurons to restore functional intracortical inhibition in chronic neuropathic pain 
[47]. In addition, tDCS of M1 may directly increase opioid release [46, 78].
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5.7. Transcranial direct current stimulation priming of repetitive transcranial 
magnetic stimulation
The physiological connectivity and neuronal plasticity of the M1 are two important factors 
that have been overlooked in the development of NIBS pain modulation protocols in the past. 
The use of tDCS-primed/preconditioned rTMS stimulation has been suggested as a more 
robust form of intervention [79, 80]. When tDCS was used to augment background motor 
corticospinal excitability, the cortical plastic changes induced by subsequent rTMSs were 
standardized. It has been demonstrated that weak 1 mA tDCS reversed the usual effects of 
rTMS on corticospinal excitability [81]. That is, preconditioning using a session of cathodal 
tDCS modified the expected suppressive effect of low-frequency rTMS and led to an overall 
cortical excitation, whereas anodal tDCS resulted in an overall motor cortical inhibition. This 
manipulation of effects is based on the conceptual form of brain plasticity, “homeostatic plas-
ticity” [82]. This protocol has been applied to the modulation of pain, and weak tDCS (1 mA) 
was used to “precondition” the brain to enhance the effects of subsequent stimulation via 
low-frequency rTMS (1 Hz) on the modulation of thermal sensation, thermal pain thresholds, 
and pressure pain thresholds, thereby producing a form of analgesia [83, 84].
5.8. Dose effects of neuromodulatory interventions
The physiological mechanism underlying the effects of tDCS remains controversial. Unlike 
pharmacological interventions for pain relief, where the appropriate dosage is carefully 
considered, the issue of “dosage” of neurostimulation has been somewhat neglected in the 
literature [85, 86]. Recent research has been working toward establishing factors responsible 
for variability in tDCS effects; such as the positioning of the electrodes on the scalp as well as 
the intensity and duration of the stimulation. This is best demonstrated in studies regarding 
application to the human motor cortex, where they attempt to direct the current to strictly 
follow the orientation of axons and/or dendrites in the induced electrical field [61]. Recent 
studies employ current flow models with defined montages [86] and use improved electrode 
positioning through the use of caps based on the international 10–20 positioning system [84].
Interestingly, there is evidence that when the electrodes are placed over the somatotopic M1 
region of the painful area, optimal analgesic effect can be obtained [27]. This could potentially 
explain some of the differences in treatment efficacy reported in rTMS studies in pain patients 
where the exact target of the stimulation in relation to the painful area is not controlled for or 
appropriately selected. A further complication to this is the variation in chronic pain condi-
tions as to the extent of spatial localization of the perceived pain.
TMS has a much longer history of research than other NIBS techniques. However, there has 
been only slow development in stimulator design. An interesting recent development has 
recently occurred in TMS that may improve future therapeutic interventions. Until recently, 
there has been a complete lack of complete experimental control over the stimulation pulse 
shape in TMS. It will be interesting to see the emerging literature as new devices develop 
that examine the differential impact of altering stimulation pulse widths and waveforms via 
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controllable TMS (c-TMS) [87]. These devices may be critical in optimizing TMS to maximize 
analgesic effects.
5.9. Combining neuromodulation with pharmacological interventions
In addition to independent efficacy, it may be that NIBS can work in a synergistic fashion 
with pharamacological interventions for pain relief. This question has been examined with 
regard to stroke recovery in large randomized control trials in an extensive research network. 
A number of recent studies have combined drug interventions with rTMS in rehabilitation in 
patients after stroke [88]. Interesting questions can be raised as to whether drug action can 
prime the brain and enhance the effect of TMS or vice versa. The same approach should be 
systematically carried out in patients with chronic pain conditions (27).
6. Challenging issues and inconsistencies in NIBS
NIBS is rapidly emerging as an intervention proposed for wide-ranging neurological and 
psychiatric disorders. However, tDCS studies have recently been scrutinized due to reported 
high degree of variability in effectiveness in published studies to date [89]. Evidence on the 
therapeutic use of both tDCS and newer methodologies like tACS are currently very limited, 
and the optimal parameters for use have yet to be fully elucidated. Many have suggested 
that there is a currently a general lack of understanding of the mechanisms by which these 
interventions are effective. However, tDCS has several advantages compared to the better 
investigated rTMS including ease of use, portability, and reduced expense [90], which sup-
port further investigation into the potential of tDCS in the treatment of pain.
Despite this, there is increasing evidence that NIBS are effective in the modulation of experi-
mentally induced pain [91] as well as chronic pain conditions although the caveat to this is 
that there is reported variability in responsiveness across studies and individuals in both 
experimental and clinical studies. This efficacy of NIBS for experimental pain challenges 
the previously held understanding that neurostimulation devices act solely by interfering 
with the long-term maladaptive plasticity associated with chronic pain. Instead, it points 
toward a general lack of sufficient mechanistic understanding as to how NIBS modulates 
pain and how this modulation differs across individuals [92]. Moves toward characterizing 
differing individual “pain phenotypes,” based on a battery of quantitative sensory testing, 
may provide insights into why some individuals respond to NIBS [7]. The use of protocols 
designed to give insights into an individual’s endogenous descending modulation such as 
conditioned pain modulation (CPM) [93] may also be useful in conjunction with NIBS, in 
the same way that these protocols have been used when differentiating groups that respond 
to pharmacological treatment interventions. Another possible reason for the variability of 
the effects of rTMS on acute pain could be differential effects on each pain modality. For 
example, it is possible that rTMS may influence A- δ –fiber-mediated and C-fiber-mediated 
pain differently [94].
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7. Is optogenetics the future of noninvasive brain stimulation?
Optogenetic techniques, where light-activated ion channels from microbial opsins are expressed 
in neurons enabling their activity to be controlled remotely by light, are rapidly increasing our 
understanding of neural circuits [95, 96]. In animal models, the technique has been used to inves-
tigate pain processing pathways; for instance, optogenetic activation of the prefrontal cortex has 
been found to lead to antinociceptive effects. This study highlighted the importance of a previously 
unexplored prefrontal to nucleus accumbens pathway that may in the future provide insights 
into treatment interventions for intractable pain [97]. As the field expands, optogenetic techniques 
are likely to lead to substantial increases in our understanding of pain processing by their use in 
animal models. In addition to the contribution to basic science, optogenetics has been predicted to 
have translational potential as a therapeutic neuromodulatory intervention for neurological disor-
ders. One of the current limitations of the use of this technology in humans will be in how to safely 
deliver the channelrhodopsin (ChR2) gene to the targeted neuronal population. Nonetheless, it is 
likely that progress will occur very rapidly in this field due to its vast therapeutic potential [98].
8. Conclusion
The use of the NIBS for the relief of pain is a relatively new field and provides an exciting 
opportunity for neuromodulatory interventions to move to targeting cortical areas rather 
than traditional spinal cord stimulation. NIBS opens up the opportunity to fully probe the 
contributions of the widespread brain areas that are thought to be associated with pain pro-
cessing in the pain neuromatrix. With the associated risk factor of mental health difficulties 
in chronic pain patients, this is particularly interesting as NIBS introduces the possibility of 
targeting cognitive-evaluative aspects of pain. Further NIBS allows experimental studies in 
healthy participants, as well as patient intervention, allowing the investigation of the neuro-
modulation of pain processing in health and disease. Taken together, these studies provide 
the potential for greater understanding of the role of descending modulation in pain percep-
tion and how this modulation is influenced by chronic pain. There is a clear need to look 
toward NIBS for future therapeutic interventions for chronic pain as there are currently a 
number of challenging chronic pain syndromes that are often refractory to conventional phar-
macological therapy [3]. With the increasing numbers seeking treatment to pain associated 
with chronic disease and injury, the development of safe and effective forms of treatment is 
crucial in terms of both public health and the economy.
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